Locations:
Search IconSearch

Clinical Trial

650×450-Scleroderma-NSIP

Trial Results Offer New Hope for Scleroderma Patients

Nintedanib significantly reduces loss of lung function

18-PUL-5877
December 21, 2018/Pulmonary/Clinical Trial

Improving Treatment Outcomes for Patients with Rheumatic Lung Disease

Three clinical trials testing old and new drugs

17-PUL-3509-Mehta-Hero-Image-650x450pxl
August 10, 2017/Pulmonary/Clinical Trial

1-Minute Consult: What Is the Role of Roflumilast in COPD?

Only for patients at high risk of severe exacerbations

Surfactant Replacement Therapy in ARDS
January 12, 2016/Pulmonary/Clinical Trial

Surfactant Replacement Therapy in ARDS

A rationale for future optimism

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Rapamycin-690×380
September 9, 2015/Pulmonary/Clinical Trial

Transplant Drug Wins FDA Approval for Rare Lung Disease

Rapamycin stabilizes lung function in LAM patients

BackPage 1 of 1Next

Advertisement

Ad